Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Single-dose Pharmacokinetic, Multiple-dose Tolerability and Pharmacokinetic Studies of Benapenem for Injection in Phase I Clinical Healthy Subjects

Trial Profile

Single-dose Pharmacokinetic, Multiple-dose Tolerability and Pharmacokinetic Studies of Benapenem for Injection in Phase I Clinical Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Jan 2019

At a glance

  • Drugs Benapenem (Primary)
  • Indications Urinary tract infections
  • Focus First in man; Pharmacokinetics
  • Sponsors Sihuan Pharmaceutical Holdings Group
  • Most Recent Events

    • 07 Jan 2019 Results of Part A, B, C (NCT03588156, NCT03578588, NCT03570970) published in the Antimicrobial Agents and Chemotherapy.
    • 11 Jul 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top